Yale Only

1. Healthcare utilization and costs for steatotic liver disease-associated hepatocellular carcinoma. 2. Biomarkers for the diagnosis and prognosis of AKI in patients with cirrhosis. 3. Refining recompensation criteria in cirrhosis

Name: 1. Healthcare utilization and costs for steatotic liver disease-associated hepatocellular carcinoma. 2. Biomarkers for the diagnosis and prognosis of AKI in patients with cirrhosis. 3. Refining recompensation criteria in cirrhosis
Start: 2025-06-24T21:00:00.0000000Z
End: 2025-06-24T22:30:00.0000000Z
Location: Yale University